EDMONTON, ALBERTA, Dec 19, 2007 (MARKET WIRE via COMTEX) -- Ceapro Inc. (CA:CZO) a Canadian growth-stage biotechnology company announces a marketing partnership and distribution agreement with French firm, Laserson S.A., for a range of seven new organic products.
Founded in 1933, Laserson distributes and develops ingredients for the health and beauty industries, from facilities on the outskirts of Paris. Laserson will act as the French distributor of Ceapro's organic active ingredients into four sectors: Cosmetics, Pharmacy, Food products, and Industry.
1. CEAPRO ICE, Certified Organic Cold Extract of Oat
2. CEAPRO GOLD, Certified Organic Extract of Oat
3. CEAPRO MAXIMUM COLLOIDAL OATMEAL, Certified Organic Colloidal Oatmeal
4. CEAPRO OAT EXFOLIANT, Certified Organic Hulls of Oat
5. CEAPRO LUPINE FLOUR, Certified Organic Sweet Lupine Flour
6. CEAPRO HYDROLYSED OAT PEPTIDES, Certified Organic Oat Protein
7. CEAPRO HYDROLYSED LUPIN PEPTIDES, Certified Organic Lupine Protein
"We see real synergies with Laserson," said Ceapro President and CEO, Mark Redmond. "Like Ceapro, they are committed to an ethic of responsible and sustainable development. Together we'll position new compounds in this expanding market, coordinating the creation and implementation of novel ingredients and solutions for multinational and domestic customers based in France."
Said Francois Laserson, Chairman of Laserson, "Our business not only consists of offering new molecules and developing new products: we combine proven technical expertise with unrivalled knowledge of regulatory affairs and marketing know-how."
Exploiting advanced functions of biochemistry, the virtues of medicinal plants and applications to sensory formulation, Laserson combines expertise and talent to stimulate product innovation and development. Specializing in the cosmetic, wellness and health industries, Laserson creates synergies where trust, creativity and precision meet to build long-term relationships. To learn more about Laserson, visit www.laserson.com.
About Ceapro Inc.
Ceapro Technology Inc., Ceapro Veterinary Products Inc., Ceapro Active Ingredients Inc. and Ceapro Bioenergy Inc. are wholly owned subsidiaries of Ceapro Inc., which is a Canadian growth-stage biotechnology company. Our primary business activities relate to the development and commercialization of organic products for medical, cosmetic and animal health industries using proprietary technology and natural, renewable resources. We will be applying our technology to become an active participant in the bioenergy sector. We have also introduced health and wellness services employing our CeaProve(R) screening technology. Ceapro shares trade on the Canadian TSX Venture Exchange under the symbol CZO. To learn more about Ceapro, visit www.ceapro.com.
The TSX Venture has neither approved nor disapproved of the information contained herein.
This release may contain forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements. Although the Company believes that the forward-looking statements contained herein are reasonable, it can give no assurance that the Company's expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.
Dr. Mark Redmond
President and CEO